Design Therapeutics (DSGN) Non-Current Assets (2020 - 2026)

Design Therapeutics has disclosed Non-Current Assets across 7 years of filings, most recently posting $3.4 million for Q1 2026.

• Non-Current Assets for Q1 2026 came in at $3.4 million, down 11.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.6 million (down 31.54% YoY), and the FY2025 annual result was $2.4 million, down 40.32% from the prior year.
• Non-Current Assets came in at $3.4 million for Q1 2026 at Design Therapeutics, up from $2.4 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $6.2 million in Q2 2022 to a low of $2.4 million in Q4 2025.
• The 5-year median for Non-Current Assets is $4.9 million (2024), against an average of $4.6 million.
• Across the five-year window, Non-Current Assets surged 4830.0% in 2022 and plunged 40.32% in 2025, its largest moves.
• Design Therapeutics' Non-Current Assets stood at $6.0 million in 2022, then fell by 15.94% to $5.1 million in 2023, then decreased by 19.89% to $4.1 million in 2024, then slumped by 40.32% to $2.4 million in 2025, then jumped by 40.26% to $3.4 million in 2026.
• The last three Non-Current Assets figures came in at $3.4 million (Q1 2026), $2.4 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.